ZBH

Zimmer Holdings Inc.

Healthcare


Presented:12/11/2013
Price:$91.88
Cap:$15.70B
Current Price:$104.60
Cap:$21.64B

Presented

Date12/11/2013
Price$91.88
Market Cap$15.70B
Ent Value$15.89B
P/E Ratio28.34x
Book Value$38.42
Div Yield0.7%
Shares O/S170.98M
Ave Daily Vol1,210,000
Short Int2.13%

Current

Price$104.60
Market Cap$21.64B
Zimmer Holdings, Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of orthopedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. The company offers orthopedic reconstructive devices that restore function lost due to disease or trauma in joints such as knees, hips, shoulders, and elbows; dental reconstructive implants, which restore function and aesthetics in patients who have lost teeth due to trauma or disease; spinal devices that are utilized by orthopedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities, and trauma in various regions of the spine; and trauma devices used primarily to reattach or stabilize damaged bone and tissue to support the body’s natural healing process. It also provides surgical products comprising surgical supplies and instruments designed to aid in orthopedic surgical procedures and post-operation rehabilitation. Its customers include orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, and healthcare dealers, as well as agents, healthcare purchasing organizations, or buying groups. The company was founded in 1927 and is headquartered in Warsaw, Indiana.

Highlights

Zimmer (ZBH) share are poised to outperform over the next 12-18 months as organic growth appears to be accelerating on the back of the recovery of the US economy and improvement in hip and knee volumes. In addition, the company has undergone a restructuring over the past two years, and may be selling two non-core, underperforming assets. The presenter sees the potential for ZBH to leverage its dry powder - and ability to take on debt – to make an immediately accretive acquisition that will boost shareholder value.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.